Trump Claims Iran Deal Largely Negotiated Including Strait of Hormuz Reopening Tehran Cautious on Nuclear Issue AI Promises Faster Cheaper Drug Discovery for Brain Disorders Like MND China Industrial Profits Surge 247 in April Fastest Pace Since Late 2023 Former JPMorgan Bankers Legal Counsel Withdraws Just Before Scheduled Court Hearing Amazons Dominance in Western ECommerce Why Rivals Have Failed to Close the Gap AnheuserBusch InBev Shares Dip on Sales Miss Market Reacts to Revenue Shortfall Nordson NDSN Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower BILL Q1 2026 Earnings EPS Surprises to the Upside Stock Declines Despite Beat Solid Power Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Discipline OPCH Q1 2026 Earnings EPS Beat Drives Modest Stock Decline Viper Energy VNOM Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Reaction UFCS Q1 2026 Earnings EPS Surges Past Estimates by 37 as Stock Declines Marathon Petroleum MPC Rallies 25 as Energy Sector Gains Momentum KimberlyClark KMB Gains 2 as Defensive Appeal Strengthens Amid Market Volatility BG Foods Inc BGS Rallies 196 as Volume Picks Up Testing Key Resistance Zone Gaia Inc GAIA Surges 5 Approaching Key Resistance at 261 Delek Logistics Partners DKL Breaks Below Key ShortTerm Support Amid Energy Sector Weakness SpaceX IPO Filing Highlights Starlinks Ambitions and Challenges for Telecom Giants AVBH Q1 2026 Earnings EPS Tops Estimates Amid Solid Core Banking Performance Twin Disc Incorporated TWIN Surges 669 Support Holds as Stock Approaches Key Resistance FORR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines BSVN Q1 2026 Earnings EPS Surges Past Estimates by 21 Satellos Bioscience Inc MSLE Q1 2026 Earnings NarrowerThanExpected Loss Marks Progress Amid PreRevenue Stage QCRH Q1 2026 Earnings EPS Beats Estimates by 85 Stock Slightly Lower MCS Q1 2026 Earnings NarrowerThanExpected Loss Lifts Investor Sentiment ABTC Q1 2026 Earnings Deep EPS Miss Highlights Operational Challenges Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD